Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clopidogrel Effect on Thrombosis in T2DM and CAD
NCT00728156Phase 4Completed
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Aug 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD) comparing Clopidogrel with Placebo (2 arms). Primary endpoint: Reduction of thrombogenicity at 7 days. Started Aug 2009; status: completed.
02
Drugs
clopidogrel
03
Conditions
type 2 diabetes mellitus (T2DM)coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00728156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00728156.